Within the organisation, the Strategic Partnering team evaluates a range of deal types including mergers and acquisitions (M&A); alliances covering more than one therapeutic area; out partnering of late stage assets; and in-licensing opportunities that do not fall within Roche’s key therapy areas of interest.
The Strategic Partnering team works closely with Disease Therapy Area heads, to provide expertise on M&A deals.